Specifically, METTL3 was found upregulated in retinoblastoma, and its silence decreased retinoblastoma malignancy by regulating PI3K/Akt signaling, probably by affecting two downstream effectors P70S6K and 4EBP1 [31]. The gene discussed is RPS6KB1; the disease is retinoblastoma.